Health Professional Radio - Podcast

Returned guest, Kent Thoelke, Chief Scientific Officer and Executive Vice President at PRA Health Sciences, a leading pharmaceutical service, healthcare data, and contract research provider discusses decentralized and virtual clinical trials and the impact on the future of pharmaceuticals. Kent Thoelke is the Chief Scientific Officer and Executive Vice President of PRA Health Sciences, a global contract research organization that is focused on clinical research as a care option (CRACCO). With almost three decades in the drug development and clinical trials industry, Mr. Thoelke has had the opportunity to participate in all levels of drug research from the bench to the bedside globally. Having had the opportunity to work in biotech, pharma and the CRO industries, he brings a unique perspective based on those experiences to the modernization of clinical trials. Mr. Thoelke is an industry pioneer and leader in the space of decentralized and virtual clinical trials and the underlying technologies that support